Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.

Utility of the Thin Prep Imaging System® in the detection of squamous intraepithelial abnormalities on retrospective evaluation: can we trust the imager?

Barroeta JE, Reilly ME, Steinhoff MM, Lawrence WD.

Diagn Cytopathol. 2012 Feb;40(2):124-7. doi: 10.1002/dc.21516.

PMID:
22246928
2.
3.
4.

Implementation of the ThinPrep imaging system in a high-volume metropolitan laboratory.

Miller FS, Nagel LE, Kenny-Moynihan MB.

Diagn Cytopathol. 2007 Apr;35(4):213-7.

PMID:
17351933
5.

[Value of computer-assisted slide-screening system in ThinPrep cervical cytology].

Yang J, Tao K, Yang H, Guo ZH, Hu YM, Tan ZY.

Zhonghua Bing Li Xue Za Zhi. 2013 Sep;42(9):609-12. Chinese.

PMID:
24314247
7.

A feasibility study of the AutoPap system location-guided screening.

Lee JS, Kuan L, Oh S, Patten FW, Wilbur DC.

Acta Cytol. 1998 Jan-Feb;42(1):221-6.

PMID:
9479344
8.

Detection of high grade squamous intraepithelial lesions and tumors using the AutoPap System: results of a primary screening clinical trial.

Wilbur DC, Prey MU, Miller WM, Pawlick GF, Colgan TJ, Dax Taylor D.

Cancer. 1999 Dec 25;87(6):354-8.

PMID:
10603189
9.

Comparison of computer-assisted and manual screening of cervical cytology.

Lozano R.

Gynecol Oncol. 2007 Jan;104(1):134-8.

PMID:
16959306
10.

Effectiveness of the SurePath liquid-based Pap test in automated screening and in detection of HSIL.

Cengel KA, Day SJ, Davis-Devine S, Adams CL, Madison-Henness D, Hartman ME, Freund GG.

Diagn Cytopathol. 2003 Nov;29(5):250-5.

PMID:
14595790
11.

Introduction of the Thin Prep Imaging System (TIS): experience in a high volume academic practice.

Chivukula M, Saad RS, Elishaev E, White S, Mauser N, Dabbs DJ.

Cytojournal. 2007 Feb 8;4:6.

12.
13.

Multicenter comparison of manual and automated screening of AutoCyte gynecologic preparations.

Bishop JW, Kaufman RH, Taylor DA.

Acta Cytol. 1999 Jan-Feb;43(1):34-8.

PMID:
9987448
14.

Utility of liquid-based cytology for cervical carcinoma screening: results of a population-based study conducted in a region of Costa Rica with a high incidence of cervical carcinoma.

Hutchinson ML, Zahniser DJ, Sherman ME, Herrero R, Alfaro M, Bratti MC, Hildesheim A, Lorincz AT, Greenberg MD, Morales J, Schiffman M.

Cancer. 1999 Apr 25;87(2):48-55.

PMID:
10227593
15.

Adenocarcinoma in situ of the uterine cervix: screening and diagnostic errors in Papanicolaou smears.

Ruba S, Schoolland M, Allpress S, Sterrett G.

Cancer. 2004 Oct 25;102(5):280-7.

16.

The AutoPap 300 QC System multicenter clinical trials for use in quality control rescreening of cervical smears: II. Prospective and archival sensitivity studies.

Patten SF Jr, Lee JS, Wilbur DC, Bonfiglio TA, Colgan TJ, Richart RM, Cramer H, Moinuddin S.

Cancer. 1997 Dec 25;81(6):343-7.

PMID:
9438459
17.
18.

HSIL, epithelial cell abnormality-adjusted workload, and the Thinprep imaging system.

Renshaw AA, Elsheikh TM.

Diagn Cytopathol. 2012 Mar;40(3):201-3. doi: 10.1002/dc.21529.

PMID:
22334521
19.
20.

A thin-layer, liquid-based pap test for mass screening in an area of China with a high incidence of cervical carcinoma. A cross-sectional, comparative study.

Pan Q, Belinson JL, Li L, Pretorius RG, Qiao YL, Zhang WH, Zhang X, Wu LY, Rong SD, Sun YT.

Acta Cytol. 2003 Jan-Feb;47(1):45-50.

PMID:
12585030
Items per page

Supplemental Content

Support Center